Join us for an essential talk on Breast Cancer awareness and research with medical oncologist, Dr. Philippe Aftimos.
With over 10,500 new cases of breast cancer detected each year in Belgium, raising awareness about research and prevention is crucial.
Scientific research is fundamental in driving significant progress, aiming to cure more breast cancer patients and reduce relapses, as well as improving quality of life.
Dr. Aftimos, co-primary investigator of Aurora — a European academic research programme utilising molecular technology to study metastatic breast cancers — will guide us through the latest advancements in treatments and prevention.
Don't miss this opportunity to learn from an expert at the forefront of breast cancer research.
An event organized in collaboration with BIG against Breast Cancer.
speaker
Philippe Aftimos, MD is a medical oncologist and the Director of the Innovative Therapies Clinic at Institut Jules Bordet, a comprehensive cancer center in Brussels.
He works in the fields of breast cancer, new drug development and precision medicine. At Institut Jules Bordet, he heads the new drug development programme at the Clinical Trials Conduct Unit. He has participated in the development of novel monoclonal antibodies and antibody-drug conjugates for the treatment of breast cancer as well as in the development of novel endocrine therapies. He currently leads multiple projects with agents targeting epigenetics. As a clinical research physician, he is a member of the think tank of the Oncodistinct network and is a member of the Scientific Executive Committee of the International Breast Cancer Study Group.
In the precision medicine field, Dr Aftimos has participated in drafting the national Belgian NGS guidelines. He is co-PI of AURORA (Aiming to Understand the Molecular Aberrations of Metastatic Breast Cancer), a large European molecular screening program launched by the Breast International Group. He is also co-PI of the Belgian Society of Medical Oncology precision medicine program, a national clinico-genomic data sharing program. He co-created and leads the Belgian national molecular tumor board.
moderator
Geraldine Vandercammen is a versatile professional with a rich background in acting, directing, voice coaching, and journalism.
Her expertise extends beyond the stage, as she has moderated debates for esteemed institutions such as ENISA, the European Commission, and WWF. Geraldine's voice has become a staple in commercials and advertisements for major brands like Apple, Dyson, and Louis Vuitton, resonating across television, radio, and online platforms in multiple languages.
Since 2020, Geraldine has expanded her scope to international journalism, collaborating with media outlets worldwide as a producer, fixer, and journalistic collaborator, bringing compelling stories to life in France.
